US Stock MarketDetailed Quotes

Protagenic Therapeutics (PTIX)

Watchlist
  • 0.4899
  • +0.0060+1.24%
15min DelayClose May 13 12:39 ET
947.90KMarket Cap-0.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagenic Therapeutics (PTIX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-174.51%-509.67K
10.08%-1.4M
29.65%-1.17M
35.63%-1.07M
-13.84%-4.22M
-819.79K
71.69%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-85.76%-3.7M
Net income from continuing operations
445.01%2.21M
45.88%-869.5K
-193.31%-5.06M
16.49%-1.44M
-10.50%-5.53M
---1.55M
54.12%-640.79K
-32.82%-1.61M
-140.12%-1.72M
-40.64%-5M
Operating gains losses
---3.11M
-294.60%-203.35K
1,251,109.09%2.48M
----
-108.21%-51.73K
--0
--0
-143.33%-51.53K
-104.47%-198
1,268.74%630.32K
Depreciation and amortization
-0.01%12.57K
0.01%12.57K
-0.01%12.57K
0.00%12.57K
78.21%50.29K
--12.57K
785.98%12.57K
13,714.29%12.57K
13,868.89%12.57K
93,960.00%28.22K
Other non cash items
--0
--2
--827.23K
----
-193.75%-80.41K
----
----
----
----
-22.59%85.77K
Change In working capital
47.33%283.09K
-156.64%-441K
510.84%448.33K
213.08%123.4K
508.65%467.54K
--556.35K
-64.75%192.15K
72.86%-171.83K
-172.69%-109.13K
-121.18%-114.41K
-Change in receivables
--2.52K
--54.59K
---25.11K
----
----
----
----
----
----
----
-Change in inventory
--1
--20
---57
----
----
----
----
----
----
----
-Change in prepaid assets
-39.46%46.85K
111.10%44.43K
-148.26%-48.27K
-110.81%-10.82K
214.40%99.63K
--322.51K
-89.96%77.39K
53.49%-400.3K
133.06%100.03K
-113.79%-87.09K
-Change in payables and accrued expense
103.66%233.72K
-336.38%-540.04K
349.46%521.77K
164.17%134.22K
1,446.40%367.92K
--233.85K
150.89%114.76K
0.39%228.46K
-295.09%-209.16K
70.17%-27.33K
Cash from discontinued investing activities
Operating cash flow
-174.51%-509.67K
10.08%-1.4M
29.65%-1.17M
35.63%-1.07M
-13.84%-4.22M
---819.79K
71.69%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-85.76%-3.7M
Investing cash flow
Cash flow from continuing investing activities
0
0
-21.59%943.18K
0
-41.31%2.8M
0
0
-0.75%1.6M
308.21%1.2M
199.03%4.78M
Net PPE purchase and sale
----
----
----
----
--0
--0
----
----
----
-8,197.78%-149.78K
Net intangibles purchase and sale
--0
----
----
----
----
----
----
----
----
----
Net business purchase and sale
--0
--0
--943.18K
----
----
----
----
----
----
----
Net investment purchase and sale
----
----
----
--0
-43.09%2.8M
--0
--0
-0.75%1.6M
308.21%1.2M
208.06%4.93M
Cash from discontinued investing activities
Investing cash flow
--0
--0
-21.59%943.18K
--0
-41.31%2.8M
--0
--0
-0.75%1.6M
308.21%1.2M
199.03%4.78M
Financing cash flow
Cash flow from continuing financing activities
-100.00%-2
-134.60%-15.41K
4.42M
102.52K
1.96M
1.6M
316.96K
44.53K
0
0
Net issuance payments of debt
--0
---15.41K
--77.76K
----
----
----
----
----
----
----
Net common stock issuance
--0
--0
--395.47K
--102.52K
--1.96M
--1.6M
--316.96K
--44.53K
--0
--0
Proceeds from stock option exercised by employees
---2
--2
--3.95M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.00%-2
-134.60%-15.41K
--4.42M
--102.52K
--1.96M
--1.6M
--316.96K
--44.53K
--0
--0
Net cash flow
Beginning cash position
194.45%2.72M
392.46%4.1M
-98.87%14.53K
42.75%1.84M
498.49%1.29M
--1.06M
321.35%924.6K
500.60%831.78K
498.49%1.29M
-60.24%215.19K
Current changes in cash
-488.18%-509.67K
-1,622.71%-1.41M
1,020.19%4.2M
-111.59%-965.5K
-48.69%549.91K
--782.27K
301.86%131.3K
15.42%92.65K
-491.34%-456.31K
370.06%1.07M
Effect of exchange rate changes
-52.81%-136
22,098.80%37.07K
-61,794.21%-117.22K
-105.79%-11
-33.17%667
--399
91.60%-89
-75.11%167
-59.31%190
-98.59%998
End cash Position
109.57%2.21M
194.45%2.72M
392.46%4.1M
4.95%872.96K
42.75%1.84M
--1.84M
588.57%1.06M
321.35%924.6K
500.60%831.78K
498.49%1.29M
Free cash flow
-174.51%-509.67K
10.08%-1.4M
29.65%-1.17M
35.63%-1.07M
-9.42%-4.22M
---819.79K
73.91%-185.66K
-1.31%-1.55M
-346.22%-1.66M
-93.10%-3.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -174.51%-509.67K10.08%-1.4M29.65%-1.17M35.63%-1.07M-13.84%-4.22M-819.79K71.69%-185.66K-1.31%-1.55M-346.22%-1.66M-85.76%-3.7M
Net income from continuing operations 445.01%2.21M45.88%-869.5K-193.31%-5.06M16.49%-1.44M-10.50%-5.53M---1.55M54.12%-640.79K-32.82%-1.61M-140.12%-1.72M-40.64%-5M
Operating gains losses ---3.11M-294.60%-203.35K1,251,109.09%2.48M-----108.21%-51.73K--0--0-143.33%-51.53K-104.47%-1981,268.74%630.32K
Depreciation and amortization -0.01%12.57K0.01%12.57K-0.01%12.57K0.00%12.57K78.21%50.29K--12.57K785.98%12.57K13,714.29%12.57K13,868.89%12.57K93,960.00%28.22K
Other non cash items --0--2--827.23K-----193.75%-80.41K-----------------22.59%85.77K
Change In working capital 47.33%283.09K-156.64%-441K510.84%448.33K213.08%123.4K508.65%467.54K--556.35K-64.75%192.15K72.86%-171.83K-172.69%-109.13K-121.18%-114.41K
-Change in receivables --2.52K--54.59K---25.11K----------------------------
-Change in inventory --1--20---57----------------------------
-Change in prepaid assets -39.46%46.85K111.10%44.43K-148.26%-48.27K-110.81%-10.82K214.40%99.63K--322.51K-89.96%77.39K53.49%-400.3K133.06%100.03K-113.79%-87.09K
-Change in payables and accrued expense 103.66%233.72K-336.38%-540.04K349.46%521.77K164.17%134.22K1,446.40%367.92K--233.85K150.89%114.76K0.39%228.46K-295.09%-209.16K70.17%-27.33K
Cash from discontinued investing activities
Operating cash flow -174.51%-509.67K10.08%-1.4M29.65%-1.17M35.63%-1.07M-13.84%-4.22M---819.79K71.69%-185.66K-1.31%-1.55M-346.22%-1.66M-85.76%-3.7M
Investing cash flow
Cash flow from continuing investing activities 00-21.59%943.18K0-41.31%2.8M00-0.75%1.6M308.21%1.2M199.03%4.78M
Net PPE purchase and sale ------------------0--0-------------8,197.78%-149.78K
Net intangibles purchase and sale --0------------------------------------
Net business purchase and sale --0--0--943.18K----------------------------
Net investment purchase and sale --------------0-43.09%2.8M--0--0-0.75%1.6M308.21%1.2M208.06%4.93M
Cash from discontinued investing activities
Investing cash flow --0--0-21.59%943.18K--0-41.31%2.8M--0--0-0.75%1.6M308.21%1.2M199.03%4.78M
Financing cash flow
Cash flow from continuing financing activities -100.00%-2-134.60%-15.41K4.42M102.52K1.96M1.6M316.96K44.53K00
Net issuance payments of debt --0---15.41K--77.76K----------------------------
Net common stock issuance --0--0--395.47K--102.52K--1.96M--1.6M--316.96K--44.53K--0--0
Proceeds from stock option exercised by employees ---2--2--3.95M----------------------------
Cash from discontinued financing activities
Financing cash flow -100.00%-2-134.60%-15.41K--4.42M--102.52K--1.96M--1.6M--316.96K--44.53K--0--0
Net cash flow
Beginning cash position 194.45%2.72M392.46%4.1M-98.87%14.53K42.75%1.84M498.49%1.29M--1.06M321.35%924.6K500.60%831.78K498.49%1.29M-60.24%215.19K
Current changes in cash -488.18%-509.67K-1,622.71%-1.41M1,020.19%4.2M-111.59%-965.5K-48.69%549.91K--782.27K301.86%131.3K15.42%92.65K-491.34%-456.31K370.06%1.07M
Effect of exchange rate changes -52.81%-13622,098.80%37.07K-61,794.21%-117.22K-105.79%-11-33.17%667--39991.60%-89-75.11%167-59.31%190-98.59%998
End cash Position 109.57%2.21M194.45%2.72M392.46%4.1M4.95%872.96K42.75%1.84M--1.84M588.57%1.06M321.35%924.6K500.60%831.78K498.49%1.29M
Free cash flow -174.51%-509.67K10.08%-1.4M29.65%-1.17M35.63%-1.07M-9.42%-4.22M---819.79K73.91%-185.66K-1.31%-1.55M-346.22%-1.66M-93.10%-3.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------Unqualified Opinion with Explanatory Notes----------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -